Development of an m6A-Related lncRNAs Signature Predicts Tumor Stemness and Prognosis for Low-Grade Glioma Patients

Figure 7

Explorations of compounds target the risk groups by CMap analysis. (a) Heatmap showing enrichment score of top 10 compounds for each LGG risk group. Compounds targeting high-risk groups were colored by red and low-risk groups in blue. (b, c) Heatmap showing each compound that shares the mechanism of actions (rows) in high- and low-risk groups. Sorted by descending number of the compound with a shared mechanism of actions.

(a)

(b)

(c)